Edition:
United States

Surmodics Inc (SRDX.OQ)

SRDX.OQ on NASDAQ Stock Exchange Global Select Market

28.75USD
14 Dec 2017
Change (% chg)

-- (--)
Prev Close
$28.75
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
13,255
52-wk High
$34.15
52-wk Low
$22.50

Latest Key Developments (Source: Significant Developments)

Surmodics Q4 gaap earnings per share $0.03
Wednesday, 8 Nov 2017 07:30am EST 

Nov 8 (Reuters) - Surmodics Inc :Surmodics reports fourth quarter fiscal 2017 results and provides fiscal 2018 guidance.Q4 non-gaap earnings per share $0.18.Q4 gaap earnings per share $0.03.Q4 revenue $20.1 million versus i/b/e/s view $17.3 million.Q4 earnings per share view $-0.01 -- Thomson Reuters I/B/E/S.Sees fy 2018 non-gaap loss per share $0.16 to $0.41.Sees fy 2018 loss per share $0.50 to $0.75.Sees fy 2018 revenue $72 million to $75 million.Fy2018 earnings per share view $0.23 -- Thomson Reuters I/B/E/S.  Full Article

Surmodics says received FDA 510(K) and CE mark clearance​
Monday, 18 Sep 2017 08:00am EDT 

Sept 18 (Reuters) - Surmodics Inc ::Surmodics announces global approvals of .014" low-profile pta balloon dilation catheter.Surmodics Inc - ‍company received FDA 510(k) and CE mark clearance​.  Full Article

Surmodics Q3 non-GAAP earnings per share $0.09
Thursday, 3 Aug 2017 07:30am EDT 

Aug 3 (Reuters) - Surmodics Inc :Surmodics reports third quarter fiscal 2017 results and updates fiscal 2017 guidance.Q3 non-GAAP earnings per share $0.09.Q3 GAAP earnings per share $0.05.Sees FY 2017 revenue $70 million to $72 million.Q3 revenue $17.8 million versus I/B/E/S view $16 million.Sees FY 2017 non-GAAP earnings per share $0.29 to $0.39.Q3 earnings per share view $-0.02 -- Thomson Reuters I/B/E/S.FY2017 earnings per share view $0.19, revenue view $67.6 million -- Thomson Reuters I/B/E/S.Sees FY 2017 earnings per share $0.15 to $0.25.  Full Article

Surmodics Q2 non-gaap EPS $0.05
Thursday, 27 Apr 2017 07:30am EDT 

April 27 (Reuters) - Surmodics Inc :Surmodics reports second quarter fiscal 2017 results, updates fiscal 2017 financial guidance.Q2 gaap earnings per share $0.04.Sees fy 2017 revenue $65 million to $68 million.Q2 revenue rose 5 percent to $17.5 million.Sees fy 2017 non-gaap earnings per share $0.15 to $0.25.Sees fy 2017 loss per share $0.02 to $+0.08.Q2 non-gaap earnings per share $0.05.Surmodics inc says narrows financial outlook for fiscal 2017.Surmodics inc says medical device revenue was $12.7 million in q2 of fiscal 2017, an increase of 9.7% compared to year-ago period.  Full Article

Surmodics reports Q1 non-GAAP earnings per share $0.19
Thursday, 2 Feb 2017 07:30am EST 

Surmodics Inc : Surmodics reports first quarter fiscal 2017 results . Surmodics reports first quarter fiscal 2017 results . Surmodics inc - raises revenue and eps guidance . Q1 revenue $17.8 million versus I/B/E/S view $15.8 million . Q1 non-GAAP earnings per share $0.19 . Surmodics Inc says remain on track to continue clinical evaluation of our surveil drug-coated balloon . Surmodics Inc- for 2017, company now expects gaap revenue to range from $64.0 million to $68.0 million, up from a previous range of $63.0 million to $67.0 million . Surmodics Inc - company now expects diluted earnings in range of loss per share of $0.07 to earnings of $0.08 per share for 2017 . Surmodics Inc sees non-GAAP earnings of $0.18 to $0.33 per share for 2017 .FY2017 earnings per share view $0.24, revenue view $65.3 million -- Thomson Reuters I/B/E/S.  Full Article

Surmodics reports Q3 non-gaap EPS $0.37
Thursday, 28 Jul 2016 07:30am EDT 

Surmodics Inc : Surmodics reports third quarter fiscal 2016 results . Raises FY 2016 non-gaap earnings per share view to $0.98 to $1.08 . Q3 gaap earnings per share $0.30 from continuing operations . Q3 revenue $20 million versus I/B/E/S view $16.3 million . Raises fy 2016 gaap earnings per share view to $0.52 to $0.59 . Sees fy 2016 revenue $68 million to $70 million . Q3 earnings per share view $0.12 -- Thomson Reuters I/B/E/S .FY2016 earnings per share view $0.78, revenue view $65.7 million -- Thomson Reuters I/B/E/S.  Full Article

SurModics Inc reaffirms FY 2016 guidance
Thursday, 28 Jan 2016 07:35am EST 

SurModics Inc:Says it is reaffirming its previously stated guidance for FY 2016.Expects revenue to range from $62 million to $66 million, with diluted GAAP earnings in range of $0.30 to $0.35 per share and non-GAAP earnings of $0.66 to $0.75 per share.  Full Article

SurModics Inc acquires NorMedix
Monday, 11 Jan 2016 08:00am EST 

SurModics Inc:Acquires Normedix, a design and development company focused on minimally invasive catheter technologies.Says Surmodics acquired normedix for $14 million, including an upfront payment of $7 million.Says other financial terms of the agreement were not disclosed.Says Surmodics is adjusting fiscal 2016 revenue guidance.Sees 2016 revenue $62 million to $66 million.Sees FY 2016 revenue guidance from a range of $60 million to $64 million to an adjusted range of $62 million to $66 million.  Full Article

BRIEF-Surmodics Q4 gaap earnings per share $0.03

* Surmodics reports fourth quarter fiscal 2017 results and provides fiscal 2018 guidance